Skip to content

Frontlight ResearchEarly access

Trial site

BloomTrials Clinical Research, LLC

Dallas, Texas 75234, United StatesNot linked to an institution yet

1closed trial

The trials here

What the trial at this site is about, from its registry record.

Conditions: Metastatic breast cancer

Closed trials

Completed
Trastuzumab Deruxtecan (DS-8201a) Versus Investigator's Choice for HER2-low Breast Cancer That Has Spread or Cannot be Surgically Removed [DESTINY-Breast04]
NCT03734029· Phase 3· Daiichi Sankyo· Source

Site data: ClinicalTrials.govUpdated 12 Nov 2026

Report an error

BloomTrials Clinical Research, LLC: trial site – Frontlight Research